{
  "resourceType" : "EvidenceVariable",
  "id" : "375183",
  "meta" : {
    "versionId" : "9",
    "lastUpdated" : "2025-11-20T13:53:03.473Z",
    "profile" : ["http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"]
  },
  "language" : "en",
  "text" : {
    "status" : "empty",
    "div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>[No data.]</p></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
        "code" : "active",
        "display" : "Active"
      }]
    }
  }],
  "url" : "https://fevir.net/resources/EvidenceVariable/375183",
  "identifier" : [{
    "type" : {
      "coding" : [{
        "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
        "code" : "ACSN",
        "display" : "Accession ID"
      }],
      "text" : "FEvIR Object Identifier"
    },
    "system" : "https://fevir.net/FOI",
    "value" : "375183",
    "assigner" : {
      "display" : "Computable Publishing LLC"
    }
  }],
  "name" : "GroupAssignment_Quadpill_vs_Candesartan",
  "title" : "GroupAssignment: Quadpill vs. Candesartan",
  "citeAs" : "GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375183. Revised 2025-11-20. Available at: https://fevir.net/resources/EvidenceVariable/375183. Computable resource at: https://fevir.net/resources/EvidenceVariable/375183#json.",
  "status" : "active",
  "author" : [{
    "name" : "Brian S. Alper, MD, MSPH"
  }],
  "publisher" : "Computable Publishing LLC",
  "contact" : [{
    "telecom" : [{
      "system" : "email",
      "value" : "support@computablepublishing.com"
    }]
  }],
  "description" : "Example of GroupAssignment Profile",
  "useContext" : [{
    "code" : {
      "system" : "https://fevir.net/resources/CodeSystem/179423",
      "code" : "evidence-communication",
      "display" : "Evidence Communication"
    },
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "GroupAssignment",
        "display" : "GroupAssignment"
      }]
    }
  }],
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "actual" : true,
  "definition" : {
    "concept" : {
      "coding" : [{
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "defined-in-handling-and-category",
        "display" : "Defined in handling and category elements"
      }]
    }
  },
  "handling" : "dichotomous",
  "category" : [{
    "name" : "Quadpill once daily",
    "valueReference" : {
      "reference" : "Group/375175",
      "type" : "Group",
      "display" : "QUARTET USA Trial Quadpill group"
    }
  },
  {
    "name" : "Candesartan 8 mg once daily",
    "valueReference" : {
      "reference" : "Group/375182",
      "type" : "Group",
      "display" : "QUARTET USA Trial Control Group"
    }
  }]
}